HPTN 084 Study Demonstrates Superiority of CAB LA to Oral FTC/TDF for the Prevention of HIV

Both cabotegravir and oral FTC/TDF have high efficacy for PrEP among women in sub-Saharan Africa Durham, N.C., Nov. 09, 2020 (GLOBE NEWSWIRE) — Researchers from the HIV Prevention Trials Network (HPTN) announced today data from the HPTN 084 clinical trial indicate that a pre-exposure prophylaxis (PrEP) regimen of long-acting cabotegravir (CAB LA) injections once every eight weeks was safe and superior to daily oral tenofovir/emtricitabine (FTC/TDF) for HIV prevention among cisgender women in sub-Saharan Africa. During a planned review of study data, an independent […]

Novavax COVID-19 Vaccine Granted Fast Track Designation by U.S. FDA

GAITHERSBURG, Md., Nov. 09, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for NVX-CoV2373, the Company’s COVID-19 vaccine candidate. Currently in late-phase clinical development, NVXCoV2373 is a stable, prefusion protein […]

Constellation Brands and E. & J. Gallo Sign Agreement With Federal Trade Commission Staff Relating to Consent Order on Pending Transaction; Constellation Provides Business Update for Fiscal 2021

VICTOR, N.Y., Nov. 09, 2020 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, announced today that it and E. & J. Gallo Winery have signed an Agreement Containing Consent Order with the Bureau of Competition of the U.S. Federal Trade Commission (FTC) regarding Gallo’s pending acquisition of a […]

Algernon Pharmaceuticals Announces Plans to Provide Interim Data from its Ifenprodil Phase 2b/3 COVID-19 Human Study

VANCOUVER, British Columbia, Nov. 09, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to announce that it plans to conduct an interim data review of its multi-national Ifenprodil Phase 2b/3 COVID-19 human study. The Company will look at the […]

Trip.com partners with global airlines to maximize customer benefits and propel travel recovery

Trip.com partners with global airlines to maximize customer benefits and propel travel recovery Trip.com partners with global airlines to maximize customer benefits and propel travel recovery SINGAPORE, Nov. 09, 2020 (GLOBE NEWSWIRE) — Trip.com, a leading international online travel service provider, has partnered with international airline brands to bring more benefits to loyalty program members. […]

Report from cyberbullying expert identifies ‘negligence’ towards student’s wellbeing at Institut Le Rosey

Source: Dr Sameer Hinduja, Co-Director of the Cyberbullying Research Center A report issued by Dr Hinduja of the Cyberbullying Research Center examines the failings at the world’s most expensive school, Le Rosey, in Switzerland The report found that the school was ‘deliberately indifferent’ to the wellbeing of the student being bullied He summarises that the […]

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications and Expansion into Oncology, Wellness and Pharma Collaborations Cambridge, United Kingdom – 9 November 2020 – Congenica, the digital health company enabling rapid and accurate analysis of […]

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications and Expansion into Oncology, Wellness and Pharma Collaborations Cambridge, United Kingdom – 9 November 2020 – Congenica, the digital health company enabling rapid and accurate analysis of […]